Big News: FDA is moving from MasterControl to ComplianceQuest.See Why
Talk to a SpecialistLoading…
Talk to a SpecialistTalk to a SpecialistBased on limited metadata, PT Sekar Subur Abadi, an Indonesian company, received an FDA Warning Letter on January 9, 2018, regarding an unspecified product type. Without access to the full letter text or subject line details, the specific nature of the regulatory violations cannot be determined from the available information. The issuing FDA office is also not identified in the metadata provided. To understand the complete scope of concerns and required corrective actions, the full Warning Letter would need to be reviewed.